Stiolto Respimat 2.736 ug/1 (Tiotropium Bromide and Olodaterol SPRAY, METERED) 2.736 ug/1

Stiolto Respimat 2.736 ug/1 is a combination inhaler containing tiotropium bromide and olodaterol. It is used for managing chronic obstructive pulmonary disease (COPD) symptoms. This metered spray helps improve breathing and reduce airway inflammation.

Strength

2.736 ug/1

Pack Size

1 CARTRIDGE in 1 CARTON (0597-0155-61) / 60 SPRAY, METERED in 1 CARTRIDGE

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Stiolto Respimat 2.736 ug/1 is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It combines tiotropium bromide, a long-acting anticholinergic, and olodaterol, a long-acting beta-agonist, to help open airways and improve breathing. This medication is often prescribed for individuals with COPD to manage symptoms such as wheezing, shortness of breath, and coughing. It is not intended for immediate relief of sudden breathing problems.

Side Effects

Common effects of Stiolto Respimat 2.736 ug/1 may include dry mouth, throat irritation, and coughing after use. Some users might experience headaches, dizziness, or muscle cramps. These effects are generally mild and temporary. If any severe or persistent effects occur, it is important to consult a healthcare provider.

Precautions & Warnings

Stiolto Respimat 2.736 ug/1 should be used as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. This medication should not be used to treat sudden breathing problems or asthma attacks. Individuals with certain medical conditions, such as heart disease or severe allergies, should discuss their health status with their healthcare provider before using this inhaler.

Avoid Interactions

Stiolto Respimat 2.736 ug/1 may interact with other medications, including beta-blockers, anticholinergics, and certain antidepressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, this inhaler should be used with caution in individuals who are sensitive to its active ingredients or any of its inactive components.

Frequently Asked Questions

Stiolto Respimat 2.736 ug/1 is used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) to improve breathing and reduce symptoms.

Stiolto Respimat 2.736 ug/1 is administered via inhalation using the provided metered spray device. Follow the instructions provided by your healthcare provider for proper use.

Common side effects may include dry mouth, throat irritation, coughing, headaches, dizziness, and muscle cramps. These effects are usually mild and temporary.

Stiolto Respimat 2.736 ug/1 is not intended for the treatment of asthma. It is specifically designed for the maintenance treatment of COPD.

If you experience severe or persistent side effects, it is important to consult your healthcare provider immediately for further guidance.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.